000 | 01948 a2200529 4500 | ||
---|---|---|---|
005 | 20250518083456.0 | ||
264 | 0 | _c20210128 | |
008 | 202101s 0 0 eng d | ||
022 | _a1613-2246 | ||
024 | 7 |
_a10.1007/s10384-020-00722-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMatsumoto, Hidetaka | |
245 | 0 | 0 |
_aOne-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions. _h[electronic resource] |
260 |
_bJapanese journal of ophthalmology _cMar 2020 |
||
300 |
_a203-209 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aChoroid _xblood supply |
650 | 0 | 4 |
_aChoroid Diseases _xdiagnosis |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorescein Angiography _xmethods |
650 | 0 | 4 | _aFundus Oculi |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntravitreal Injections |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPhotochemotherapy |
650 | 0 | 4 |
_aPhotosensitizing Agents _xtherapeutic use |
650 | 0 | 4 |
_aPolyps _xdiagnosis |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xadministration & dosage |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTomography, Optical Coherence |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
650 | 0 | 4 | _aVisual Acuity |
700 | 1 | _aMukai, Ryo | |
700 | 1 | _aKikuchi, Yuka | |
700 | 1 | _aMorimoto, Masahiro | |
700 | 1 | _aAkiyama, Hideo | |
773 | 0 |
_tJapanese journal of ophthalmology _gvol. 64 _gno. 2 _gp. 203-209 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10384-020-00722-7 _zAvailable from publisher's website |
999 |
_c30594454 _d30594454 |